23andMe SPAC Presentation Deck

Our 23andMe I/O Asset, P006, is a Potent Activator of Human T Cells Suppressed by Tumor Antigen P006 pathway has a strong I/O signature unique to the 23and Me database Cancer Immune T F P006 receptor P006 ligand Immune APC Cancer Ligand Receptor Signaling protein Cancer cell P006 blocks tumor suppression of T cells and activates immune response Antibody Against P006 Receptor APC P006 ligand is strongly expressed in a subset of human tumors Immunohistochemistry for P006 ligand in Small Cell Lung Cancer >>> Stage Commit to candidate selection Phase 1 Phase 2 Initiation of Phase 1 is planned for CY21 CY21 Q1 Q2 Q3 Q4 IND CY22 Q1 Q2 Q3 Q4 23andMe Confidential and Proprietary Information 29

View entire presentation